Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fractionRungroj Krittayaphong, Unchalee Permsuwan|International Journal of Cardiology|2020Cited by 54
Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in ThailandUnchalee Permsuwan, Tawesak Tanwandee, Maneerat Chayanupatkul et al.|Applied Health Economics and Health Policy|2022Cited by 5
Simplified Chronic Hepatitis B Antiviral Initiation Criteria in Thailand: An Economic EvaluationPiyameth Dilokthornsakul, Unchalee Permsuwan, Ratree Sawangjit et al.|Value in Health Regional Issues|2024Cited by 2
Risk prediction algorithms in guiding antiviral therapy initiation among patients with chronic hepatitis B in Thailand: an economic evaluation and budget impact analysisPiyameth Dilokthornsakul, Unchalee Permsuwan, Ratree Sawangjit et al.|Expert Review of Pharmacoeconomics & Outcomes Research|2023Cited by 1
WED-502 Simplified criteria for antiviral initiation in patients with chronic HBV infection: an economic evaluation and budget impact analysis in ThailandPisit Tangkijvanich, Piyameth Dilokthornsakul, Unchalee Permsuwan et al.|Journal of Hepatology|2024Cited by 0